{
    "title": "U.S. FDA flags risk of heart inflammation after Novavax COVID vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10882075/U-S-FDA-staff-says-Novavax-vaccine-lowers-COVID-risk.html",
    "date": "2022-06-03",
    "keywords": [
        "vaccine",
        "trial",
        "myocarditis",
        "heart",
        "inflammation",
        "covid19",
        "staff",
        "company",
        "roy",
        "risk",
        "companys",
        "disease",
        "shot",
        "causal",
        "association",
        "fda",
        "efficacy",
        "june",
        "food",
        "drug",
        "administration",
        "december",
        "type",
        "concern",
        "analysis",
        "agency",
        "kind",
        "pericarditis",
        "response",
        "safety",
        "background",
        "database",
        "interpretation",
        "evidence",
        "relationship",
        "statement",
        "patient",
        "placebo",
        "novavax",
        "nvxcov2373",
        "role",
        "vaccination",
        "effort",
        "availability",
        "pandemic",
        "desire",
        "wellunderstood",
        "technology",
        "omicron",
        "variant",
        "estimate",
        "level",
        "protection",
        "novavaxs",
        "study",
        "note",
        "meeting",
        "agencys",
        "decision",
        "tuesday",
        "advise",
        "reporting",
        "bengaluru",
        "michael",
        "erman",
        "jersey",
        "editing",
        "chakrabarty",
        "david",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}